Healthcare

Image

Global Adrenal Cancer Diagnostics Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Adrenal Cancer Diagnostics Market, By Tumor Type (Pheochromocytoma, Adrenal Cortical Carcinoma, Others), Treatment (Surgery, Chemotherapy, Radiotherapy, Targeted Cancer Therapies, and Others), Test (Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, X-ray, Positron Emission Tomography (PET) Scan, Biopsy), End-User (Hospitals, Ambulatory Surgical Centers, Cancer Centers, Others) – Industry Trends and Forecast to 2030.

Adrenal Cancer Diagnostics Market

 Adrenal Cancer Diagnostics Market Analysis and Size

The rising number of cancer cases worldwide is one of the major factors driving industry growth during the forecast period. Furthermore, supportive government initiatives and increasing awareness are expected to drive growth during the forecast period. For instance, the Biden-Harris administration has set a goal of reducing cancer mortality by 50% over the next 25 years and improving the knowledge of people living with and surviving tumours.

Data Bridge Market Research analyses that the adrenal cancer diagnostics market which was USD 130 billion in 2022, is expected to reach USD 207.20 billion by 2030, at a CAGR of 6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Adrenal Cancer Diagnostics Market Scope and Segmentation      

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Tumor Type (Pheochromocytoma, Adrenal Cortical Carcinoma, Others), Treatment (Surgery, Chemotherapy, Radiotherapy, Targeted Cancer Therapies, and Others), Test (Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, X-ray, Positron Emission Tomography (PET) Scan, Biopsy), End-User (Hospitals, Ambulatory Surgical Centers, Cancer Centers, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Annon Piezo Technology Co. LIMITED. (China), APC International, Ltd. (U.S.), GSK plc (U.K.), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (U.S.), AstraZeneca (U.K.), Siemens Healthcare GmbH (Germany), Bio-Rad Laboratories, Inc. (U.S.), Abbott (U.S.), TRS Technologies, Inc. (U.K.), Teledyne Defense Electronics (U.S.), TAIYO YUDEN CO., LTD. (Japan), Morgan Advanced Materials (U.K.)

Market Opportunities

  • Rising prevalence of cancer

Market Definition

Adrenal cancer is a rare type that starts in one or both of the small, triangular glands (adrenal glands) on top of your kidneys. The adrenal glands produce hormones that instruct nearly every organ and tissue in your body. Adrenal cancer, also known as adrenocortical cancer, can strike anyone at any age. However, it is more likely to affect children under the age of five and adults in their 40s and 50s.

Global Adrenal Cancer Diagnostics Market Dynamics

Drivers

  • Increasing incidence of adrenal cortical carcinoma

Increasing incidence of adrenal cortical carcinoma due to the spread of other types of cancer, advancement in imaging technologies to specifically identify adrenal cortical tumours, rising healthcare expenditure, and an increase in the number of cancer treatment centres globally are some of the dominant factors are fuelling the growth of the global adrenal cancer diagnostics market during the forecast period. For instance, Adrenal cortical carcinoma is a rare and aggressive cancer, according to the Journal of Clinical Endocrinology and Metabolism. Adrenal cortical carcinoma occurs at a rate of 0.7-2.0 cases per million people. Women are more likely to contract the disease. It is most commonly diagnosed between the ages of 40 and 50. These are the certain factors which propel the growth of the market.

  • Rise in the geriatric population

According to GLOBOCAN, approximately 19.3 million new cancer cases were reported worldwide in 2020, with this figure expected to rise to 30.2 million new cases by 2040. According to the World Health Organization factsheet, cancer accounts for approximately one out of every six deaths worldwide. Cancer kills roughly 70% of people in low- and middle-income countries. The rise in the geriatric population and an increase in cancer cases are the major factors driving the growth of the adrenal cancer diagnostics market.

Opportunities

  • Rising prevalence of cancer

Cancer is one of the leading causes of death worldwide, and its prevalence is increasing at an alarming rate. As a result, healthcare professionals are concentrating their efforts on the development of effective screening and treatment solutions to reduce prevalence levels. Early screening improves treatment regimen success rates. As a result, healthcare agencies and market players are promoting routine check-ups and screenings through various awareness programmes. For instance, in March 2022, HHS announced USD 5 million in funding to improve equity in cancer screening at health centres.

Restraints/Challenges

  • High cost associated diagnostic imaging system

The rising demand for cancer diagnostic tests, combined with technological advancements that provide faster results and greater accuracy, has driven up the cost of adrenal cancer diagnostics. The use of imaging diagnostics in the industry has increased exponentially over the last decade. However, it has been observed in several countries that several cancer diagnostic services are not fully covered by insurance.

Beckwith-Wiedemann syndrome is a growth disorder characterized by a large body and organs. Individuals with this syndrome are also at risk for kidney and liver cancer.

This adrenal cancer diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the adrenal cancer diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Adrenal Cancer Diagnostics Market

The COVID-19 pandemic had a negative impact on cancer care programmes and the cancer market in many countries. Furthermore, the onset of the COVID-19 pandemic hampered R&D programmes involving product development and clinical trials focusing on cancer diagnostics. Medical device manufacturers and other supply chain stakeholders placed a high priority on developing and producing COVID-19-related goods and ancillaries.

Global Adrenal Cancer Diagnostics Market Scope

The adrenal cancer diagnostics market is segmented on the basis of tumor type, treatment, test, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Tumor Type

  • Pheochromocytoma
  • Adrenal Cortical Carcinoma
  • Others

Treatment

  • Surgery
  • Chemotherapy
  • Radiotherapy
  • Targeted Cancer Therapies
  • Others

 Test

  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT) Scan
  • X-ray
  • Positron Emission Tomography (PET) Scan
  • Biopsy

 End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Cancer Centers
  • Others

Adrenal Cancer Diagnostics Market Regional Analysis/Insights

The adrenal cancer diagnostics market is analyzed and market size insights and trends are provided by country, tumor type, treatment, test, and end-user as referenced above.

The countries covered in the adrenal cancer diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the adrenal cancer diagnostics market due to the availability of numerous bio-technology as well as medical device companies and high adoption of advanced technologies in this region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the availability of a large patient pool, skilled technicians at a comparatively lower price, and a defined regulatory framework favouring expedited product approvals in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The adrenal cancer diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for adrenal cancer diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the adrenal cancer diagnostics market. The data is available for historic period 2011-2021.

Competitive Landscape and Adrenal Cancer Diagnostics Market Share Analysis

The adrenal cancer diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to adrenal cancer diagnostics market.

Some of the major players operating in the adrenal cancer diagnostics market are:

  • Annon Piezo Technology Co.,LIMITED. (China)
  • APC International, Ltd. (U.S.)
  • GSK plc (U.K.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Johnson & Johnson Services, Inc. (U.S.)
  • AstraZeneca (U.K.)
  • Siemens Healthcare GmbH (Germany)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Abbott (U.S.)
  • TRS Technologies, Inc. (U.S.)
  • Teledyne Defense Electronics (U.S.)
  • TAIYO YUDEN CO., LTD. (Japan)
  • Morgan Advanced Materials (U.K.)

Research Methodology: Global Adrenal Cancer Diagnostics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report. 


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Adrenal Cancer Diagnostics Market size will be worth USD 207.20 billion by 2030.
The Adrenal Cancer Diagnostics Market growth rate is 6% by 2030.
Rise in the geriatric population and Increasing incidence of adrenal cortical carcinoma are the growth drivers of the Adrenal Cancer Diagnostics Market.
The tumor type, treatment, test, and end-user are the factors on which the Adrenal Cancer Diagnostics Market research is based.
The major companies in the Adrenal Cancer Diagnostics Market are Annon Piezo Technology Co. LIMITED. (China), APC International, Ltd. (U.S.), GSK plc (U.K.), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (U.S.), AstraZeneca (U.K.), Siemens Healthcare GmbH (Germany), Bio-Rad Laboratories, Inc. (U.S.), Abbott (U.S.), TRS Technologies, Inc. (U.K.), Teledyne Defense Electronics (U.S.), TAIYO YUDEN CO., LTD. (Japan), Morgan Advanced Materials (U.K.).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials